首页> 外文期刊>Internal medicine journal >Multidrug-resistant Acinetobacter: a threat to the antibiotic era.
【24h】

Multidrug-resistant Acinetobacter: a threat to the antibiotic era.

机译:多重耐药性不动杆菌:对抗生素时代的威胁。

获取原文
获取原文并翻译 | 示例
           

摘要

Multidrug-resistant Acinetobacter has now emerged as an impressive organism, with unique skills of adaptation that will allow it to persist as a problem well into the future. The epidemiology of this organism is complex and emphasizes the importance of use of molecular tools in outbreak investigation. The challenges of antimicrobial treatment are mounting and have led clinicians to seek older or non-traditional agents in an attempt to maximize patient outcomes. Our ability to differentiate colonization from infection is of critical importance, especially for respiratory samples, as inappropriate antibiotic use will only add fuel to an already raging fire. Future research should be targeted towards the most effective strategies to prevent the spread of multidrug-resistant Acinetobacter, as well as, new or novel therapeutics for the treatment of highly resistant Gram-negative bacilli, including Acinetobacter.
机译:耐多药性不动杆菌现已成为令人印象深刻的有机体,具有独特的适应能力,可使其在未来一直作为问题继续存在。这种生物的流行病学很复杂,并强调了在暴发调查中使用分子工具的重要性。抗菌治疗的挑战日益严峻,并已导致临床医生寻求较老的或非传统的药物,以最大程度地提高患者的治疗效果。我们区分殖民地与感染的能力至关重要,尤其是对于呼吸道样本,因为不当使用抗生素只会增加本来就很火的燃料。未来的研究应该针对最有效的策略,以防止多重耐药性不动杆菌的传播,以及用于治疗高度耐药的革兰氏阴性杆菌(包括不动杆菌)的新疗法或新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号